Immunosuppressants API Market

1. Immunosuppressants API Market Business overview, Upcoming Trends and Top Company Analysis Forecast – 2028 Immunosuppressants API market is anticipated to grow at a CAGR of 8.2% during the forecast period. The rising number of organ transplants globally is one of the prominent factors that has surged the demand for immunosuppressant API drugs. Immunosuppressants help prevent organ rejection. As per the United Network for Organ Sharing, in 2021, around 41,355 organ transplants were performed. Of which 24,670; 9,236; 3,817; and 2,524 accounted for kidney, liver, heart, and lung respectively. In addition, 106,131 people need a lifesaving organ transplant, of which people need a lifesaving organ transplant. Constant technological advancements in tissue engineering are also crucial factors enhancing the overall market development. The market growth is also backed by the growing geriatric population, increasing prevalence of autoimmune diseases, and rapid growth in the biopharmaceuticals sector. To Request a Sample of our Report on Immunosuppressants API Market https://www.omrglobal.com/request-sample/immunosuppressants-api-market However, certain factors that can act as major impediments to the growth of the market include the high costs associated with API and the lack of availability of organ donors. Moreover, rising US FDA drug approvals can bring new growth opportunities for the market players. For instance, in August 2019, AbbVie, a research-based global biopharmaceutical company got US FDA approval from RINVOQ (upadacitinib), a once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with moderately to severely active rheumatoid arthritis (RA). A full Report of Immunosuppressants API Market is available @ https://www.omrglobal.com/industry- reports/immunosuppressants-api-market Company Profiles AbbVie, Inc. Accord Healthcare, Ltd. Biocon, Ltd. Bristol-Myers Squibb, Co. Chunghwa Chemical Synthesis & Biotech Co. Ltd. Concord Biotech, Ltd. GlaxoSmithKline PLC Glenmark Pharmaceuticals, Inc. Hoffmann-La Roche AG. Jiangsu Jiuyang Bio-Pharmaceutical Co. Ltd NATCO Pharma, Ltd. Pfizer, Inc. RPG Life Sciences, Ltd. Triveni Interchem Pvt., Ltd. Zhejiang Hisun Pharmaceutical Co. Ltd.

2. Market Segmentation Global Immunosuppressants API Market by Type Corticosteroids Janus Kinase Inhibitor Calcineurin Inhibitors mTOR Inhibitor Others Global Immunosuppressants API Market by Method Synthetic Chemistry Peptide Chemistry Fermentation Chromatographic Purification Global Immunosuppressants API Market by Application Autoimmune Disease Organ Transplant Global Immunosuppressants API Market by Product Tablets Capsules Liquids Injections Global Immunosuppressants API Market by End-User Biotechnology & Biopharmaceutical Co. CMOs CROs CDMOs .Other For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/immunosuppressants-api-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. Media Contact Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404